ADC Therapeutics Discontinues Zynlonta Trial After 7 Deaths Led to An FDA Partial Hold

ADC Therapeutics Discontinues Zynlonta Trial After 7 Deaths Led to An FDA Partial Hold

ADC Therapeutics, a biotechnology company, has decided to discontinue its Zynlonta trial following a partial clinical hold imposed by the…

Read More »